Alzheimer’s Therapeutic Research Institute
About the Institute
Located in San Diego, the institute is an integral part of the Keck School of Medicine of USC’s mission to create a leading hub of basic, translational and clinical research in neuroscience and neurological diseases by collaborating with sites and investigators around the world. USC ATRI promotes extensive collaboration and data sharing across academia, industry, regulators and advocacy groups with a focus on training future leaders in AD clinical research.
USC ATRI is funded by the National Institutes of Health (NIH), the Alzheimer’s Association, the Department of Defense, the pharmaceutical partners and advocacy groups to develop novel methods and engage in all phases of AD clinical trials as well as observational studies. Bringing broad expertise to a comprehensive array of partners, USC ATRI manages a portfolio of national and international multi-site studies.
Learn more about ATRI
Researchers discover what may be earliest stage of Alzheimer’sClusters of a sticky protein — amyloid plaque — found in the brain signal mental decline years before symptoms appear, a new study finds. Older adults with elevated levels of brain-clogging plaques — but otherwise normal cognition — experience faster mental decline suggestive of Alzheimer’s disease, according to a… Read More »
Keck School Events
08/21/2017 - 08/25/2017
USC Health Sciences Campus, Los Angeles, CA